- $1.30bn
- $1.74bn
- $689.18m
- 66
- 68
- 47
- 63
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 607 | 548 | 624 | 654 | 689 |
Cost of Revenue | |||||
Gross Profit | 444 | 385 | 432 | 450 | 467 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,053 | 1,437 | 575 | 588 | 635 |
Operating Profit | -446 | -889 | 48.3 | 66 | 54.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -475 | -936 | 9.48 | 22.6 | 18.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -445 | -789 | 10.8 | 17.2 | 118 |
Net Income Before Extraordinary Items | |||||
Net Income | -445 | -789 | 10.8 | 17.2 | 118 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -445 | -789 | 10.8 | 17.2 | 118 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.01 | -2.96 | 0.163 | 0.258 | 1.76 |